Ischemic Heart Disease/MI Review

Slides:



Advertisements
Similar presentations
INTERVENTIONAL CARDIOLOGY AN OVERVIEW
Advertisements

Patient Oriented Therapy Non STE ACS
Reperfusion Strategies for ST elevation MI.
Chapter 3 for 12 Lead Training -Precourse-
Presented by: Fahim H. Jafary, M.D., F.A.C.C. Associate Professor of Medicine Aga Khan University Hospital, Karachi March 14, 2008 Primary Percutaneous.
Guidelines recommend consideration of fibrinolytic therapy if unable to achieve a door to balloon time ≤120 minutes for STEMI patients transferred for.
A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction.
Acute coronary syndrome : Risk stratification – markers of myocardial necrosis Paul Calle Emergency Department Ghent University Hospital Belgium.
“ If physicians would read two articles per day out of the six million medical articles published annually, in one year, they would fall 82 centuries behind.
A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
STEMI: What’s the Rush? STEMI: What’s the Rush? William Phillips, MD, FACC, FSCAI Director of Cardiology CMMC A PCI Center perspective.
Primary PCI Treatment of choice for Acute MI.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Ten Points to Remember from the 2007 STEMI Guideline Update Based on the 2007 Focused Update of the 2004 Guidelines for the Management of Patients With.
ACS and Thrombosis in the Emergency Setting
AMI Strategy How to Achieve Door-to-Balloon Times of 90 Minutes and What to Do Next? Aaron Kugelmass, MD Director, Cardiac Cath Lab Associate Division.
Amy Gutman MD EMS Medication Director
Acute STEMI: current approach
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.
Management Of AMI Does time matter?? What is the best strategy: PPCI Vs TT.
ACC/AHA Guidelines for the Management of Patients with ST Elevation Myocardial Infarction; 2004 Ahmad Aslam, M.D. Prasantha Bathini, M.D. Robert Smith,
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
False Positive ST Elevation in Patients Undergoing Direct Percutaneous Coronary Intervention David M. Larson MD, Katie M. Menssen, BS,, Scott W Sharkey.
TACTICS- TIMI 18 Treat Angina with Aggrastat TM and Determine Cost of Therapy with an Invasive or Conservative Strategy.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
No conflicts of interest or financial ties to disclose.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Acute Coronary Syndrome
Challenges in Pre Hospital Diagnosis & Management of Acute MI
Prehospital NSTEMI Patient Assessment and Treatment
CPR in ACUTE CORONARY SYNDROM
Risk Stratification of Chest Pain: Best Practices
The American College of Cardiology Presented by Dr. Adnan Kastrati
CORONARY ARTERY DISEASE
CRT 2017 Interventional Challenging Case Anterior ST- Elevation Myocardial Infarction Resulting From Acute Occlusion of Left Internal Mammary Artery Graft.
CHEST PAIN.
Management of ST-Elevation Myocardial Infarction
Coronary artery disease
Glenn N. Levine et al. JACC 2016;68:
Chapter 28 Management of Patients With Coronary Vascular Disorders
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
European Heart Association Journal 2007 April
Eugene Braunwald, MD, Marc S. Sabatine, MD, MPH 
Section F: Clinical guidelines
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
American College of Cardiology Presented by Dr. Michel R. Le May
Global Registry of Acute Coronary Events: GRACE
Acute Coronary Syndrome (1)
What oral antiplatelet therapy would you choose?
Maintenance of Long-Term Clinical Benefit with
Train-the-Trainer Cases
Management of AMI in patients presenting with STEMI
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.
Train-the-Trainer Cases
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Ischemic Heart Disease/MI Review R. Keith Bailey, MD, MPAS VAPAA Conference Houston, Tx 2017

Nothing to report regarding conflicts of interest Sponsored by VAPAA

Acute Coronary Syndromes UA: Unstable Angina Rapidly worsening chest pain of cardiac etiology No ST segment elevation on the admitting ECG Negative serial troponin blood tests NSTEMI: Non-ST segment elevation MI Positive serial troponin blood tests STEMI: ST segment elevation MI Prolonged chest pain of cardiac etiology ST elevation or new LBBB on the admitting ECG Troponin not required for the diagnosis (but ++)

STEMI Definition Acute Clinical Syndrome, ongoing for at least 30 minutes A Diagnostic ECG (done within 10 minutes of arrival to ER): >1 mm ST elevation in two anatomically contiguous leads New Left Bundle Branch Block (LBBB) No Alternative Explanation Acute Pericarditis, Aortic Dissection, Pneumothorax, Pancreatitis, Pulmonary Embolus

TIMI IIIB Results % Mortality at 42 days Troponin I Predicts Mortality in UA/NSTEMI 7.5 8 6.0 6 % Mortality at 42 days 3.7 3.4 4 1.7 2 1.0 831 174 148 134 50 67 0 to <.04 0.4 to <1.0 1.0 to <2.0 2.0 to <5.0 5.0 to <9.0 > 9.0 Cardiac Troponin I ng/ml Risk Ratio 1.0 1.8 3.5 3.9 6.2 7.8 Antman EM, NEJM 1996;335:1342

60 yo male presents to the ER with severe epigastric pain which radiated to his throat and arm. Risk Factors for CAD included: Hypertension, hyperlipidemia, Diabetes Mellitus, positive family history and Smoking 2 ppd for 40 yrs. PH no previous admissions or hospitalizations Physical Examination: BP 90/50 P 65/min remainder of his physical examination except for a systolic murmur was normal ECG -

Myocardial Infarction Anastomoses / Collateral Circulation

Angina Pectoris

Arterial Plaque

Coronary Atherosclerosis

Blockage Treatment

ISIS–2 INTERNATIONAL INFARCT STUDY OF INFARCT SURVIVAL CARDIOVASCULAR MORTALITY AT 4 WEEKS TREATMENT MORTALITY % Streptokinase 10.4 Aspirin 10.7 Aspirin + Streptokinase 8.0 Placebo 13.2

Andreas Gruentzig, M.D. 1939-1985 In September 1977, in Zurich Switzerland, Gruentzig performed the first coronary angioplasty on an awake human. "I want to do the least necessary to help the patient heal themselves". Plane crash October 1985

Who Should Get Primary PCI? “Generally preferred” in patients presenting with < 3 hours symptoms if : Door to balloon time is < 90 minutes (Door to balloon) – (door to needle) is < 1 hour Otherwise lytics are the preferred alternative In High Risk STEMI (acute pulmonary edema or shock) In those with a contraindication to lytics In patients presenting > 3 hours from symptom onset (door to balloon time “as brief as possible”, with goal <90 minutes)

ACC/AHA Guidelines for Primary PCI “The procedure should be supported…in an appropriate laboratory (one that performs more than 200 PCI procedures per year, of which at least 36 are primary PCI for STEMI, and that has cardiac surgery capability.”

ACC/AHA Guidelines for PCI in Acute STEMI “If immediately available, primary PCI should be performed in patients with STEMI who can undergo PCI of the infarct artery within 12 hours of symptom onset, if performed in a timely fashion (balloon inflation within 90 minutes of presentation) by persons skilled in the procedure (individuals who perform> 75 PCI procedures per year).”

Why is PCI Listed as Preferable to Thrombolysis? Very effective at opening the occluded artery With PCI: 90% - 95% patency rate, regardless of symptom duration With lytics: 50% to 70% within 2 hrs of symptom onset ~30% at 4-6 hrs ~20% >6 hrs Stenting removes residual stenosis Allows complete staging of CAD extent – CABG Focuses resuscitation/initial treatment efforts

Complication Thrombolytic therapy vs Primary PTCA 10 trial meta-analysis JAMA 1997;278:2093-8.)

ACC/AHA Guidelines for PCI in Acute STEMI “If immediately available, primary PCI should be performed in patients with STEMI who can undergo PCI of the infarct artery within 12 hours of symptom onset, if performed in a timely fashion (balloon inflation within 90 minutes of presentation) by persons skilled in the procedure (individuals who perform> 75 PCI procedures per year).”

TIMI 1 Open Artery Theory Impact of 90 Minute Patency on Mortality Patent (N=161) 20 Occluded (N=128) 15 10 Mortality (%) 5 As seen in this figure, patients with a patent artery (yellow) at 90 minutes after the start of reperfusion therapy had lower 6 month and 1 year mortality regardless of treatment group. 8 16 24 32 40 48 Weeks from Randomization Dalen, et. al. Am J Cardiol 1988; 62:179-85

Time when thrombolytics started Lives saved/1000 compared to Standard Rx Time when thrombolytics started In the first hour 65 In the second hour 37 In the third hour 29 Between hours 3-6 26 Between hours 6 and 12 18 Between hours 12 and <24 9

Assessment of Reperfusion Options- STEMI Step I – Assess time and risk Time since onset of symptoms Risk of STEMI Risk of fibrinolysis Time required for transport to a skilled PCI Lab

Step II – Determine if fibrinolysis or an invasive strategy is preferred. Fibrinolysis is generally preferred if: Early presentation (less than or equal to three hours from symptom onset and delay to invasive strategy) Invasive strategy is not an option Cath lab occupied/ not available Vascular access difficulties Lack of access to a skilled PCI lab Delay to invasive strategy Prolonged transport Door to balloon > 90 minutes

Contraindications for Fibrinolytic therapy in ST Elevation MI Absolute Contraindications Any prior intracranial hemorrhage Known structural cerebral vascular lesion (e.g. AVM) Known malignant intracranial neoplasm (primary or metastatic)

Contraindications for Fibrinolytic therapy in ST Elevation MI Absolute Contraindications Ischemic stroke within 3 months Suspected aortic dissection Active bleeding or bleeding diathesis (except menses) Significant closed head or facial trauma within 3 months

An invasive strategy is generally preferred if: Skilled PCI lab available with surgical backup Skilled PCI lab with surgical backup Door to balloon < 90 minutes High risk ST elevation MI Cardiogenic shock Killip class > or equal to III Contraindications to fibrinolysis including increased risk of bleeding and ICH Late presentation Symptom onset was > 3 hours ago Diagnosis of ST elevation MI is in doubt

0.5% of interventional patients go emergently/urgently to bypass because of Acute occlusion during attempts to cross a lesion with a guide wire or after inadvertent loss of guide wire access across the lesion. Dissections of the left main coronary artery or across major branches. Hemodynamic embarrassment. Recurrent occlusion after stenting. Perforation of a coronary vessel.

0.5% of interventional patients go emergently/urgently to bypass because of Dissection of the Aorta Extensive coronary dissection uncontrollable by stenting. Inability to pass a stent. Stent maldeployment.

Acute Coronary Syndrome Performance Measures Inpt ECG in hospital within 15 minutes prior to or 10 minutes after arrival Inpt Reperfusion as appropriate STEMI Inpt Reperfusion PCI in 120 min STEMI

Acute Coronary Syndrome Performance Measures Inpt Reperfusion Thrombolytic Rx in 30 min STEMI Inpt Risk High/Moderate seen by cardiologist within 60 days post discharge Inpt Risk High//Moderate with cardiology involvement in 24 hours

Acute Coronary Syndrome Performance Measures Inpt Risk High/Moderate with Dx cath prior to discharge Inpt Risk Moderate/Low with plan prior to discharge Inpt Troponin returned within 60 minutes of initial order

Conclusions In patients with STEMI with <12 hrs of symptoms reperfusion vs no reperfusion is best In patients with < 3hrs of symptoms, PCI is preferred reperfusion strategy if it can be delivered in a “timely”fashion Door to balloon time < 90 (120) minutes (Door to balloon) – (Door to needle) time < 60 minutes The longer from symptom onset ( > 3 hours), the more attractive PCI becomes Thrombolytic reperfusion success rate decreases with time PCI reperfusion success rate may not

Conclusions Remember the Time is Muscle and Time is Life If you transfer all STEMI patients to another hospital, MEASURE cumulative door to balloon times If times are sub-optimal > 90 minutes, consider giving Fibrinolytics in the absence of contraindications The efficacy of facilitated PCI with GPIIb/IIIa + half dose lytic is under investigation Clopidogel + lytics may also be an approach in certain patients

VHA Where we stand As of January 2017 : 79 operating cardiac catheterization labs 10% offer 24/7 coverage EMS transports Remainder offer elective Mon-Fri diagnostic procedures/ emergent PTCA or transport to backup facility Usually Affiliated University or community based

"Do, or do not. There is no 'try'." ('The Empire Strikes Back') Yoda ('The Empire Strikes Back')